Small cell carcinoma of the prostate presenting with skin metastasis: A case report

Journal of Medical Case Reports

Volumn 8, Issue 1, 2014, Pages

  Cecen, Kursat ^a   Karadag, Mert Ali ^a   Demir, Aslan ^a   Kocaaslan, Ramazan ^a  

^a KAFKAS UNIVERSITY   (Turkey)

Author keywords

Prostatic carcinoma; Skin metastasis; Small cell carcinoma

Indexed keywords

CISPLATIN; ETOPOSIDE; PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SMALL CELL CARCINOMA; SKIN METASTASIS; SMALL CELL CARCINOMA; TRANSRECTAL ULTRASONOGRAPHY; ADENOCARCINOMA; LIVER TUMOR; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PROSTATE TUMOR; SECONDARY; SKIN TUMOR;

ADENOCARCINOMA; AGED; CARCINOMA, SMALL CELL; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM, RESIDUAL; PROSTATIC NEOPLASMS; SKIN NEOPLASMS;

EID: 84902288017     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-8-146     Document Type: Article

References (14)

1. Basal cell carcinoma of the prostate: a case report and review of the literature. Eldefrawy A, Katkoori D, De Los Santos R, Manoharan M, Soloway MS, Uro Today Int J 2009 2 3 doi:10.3834/uij.1944-5784.2009.06.11
2. Premalignant and malignant prostate lesions: pathologic review. Shohreh ID, Cancer Control 2010 17 4 214 222 20861809
3. Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Yashi M, Terauchi F, Nukui A, Ochi M, Yuzawa M, Hara Y, Morita T, Urol Oncol 2006 24 313 317 10.1016/j.urolonc.2005.08.022 16818183
4. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Helpap B, Kollermann J, Oehler U, Urol Int 1999 62 133 138 10.1159/000030376 10529661
5. Small cell carcinoma of the prostate. Umar SA, Maclenna GT, J Urol 2009 181 2 838 839 10.1016/j.juro.2008.11.006 19095268
6. Small cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model? Barcons LAL, Asian J Androl 2010 12 308 314 10.1038/aja.2009.68 20023690
7. Prostate cancer with a normal PSA: small cell carcinoma of the prostate-a rare entity. Trotz C, JABFP 2003 16 4 343 344 10.3122/jabfm.16.4.343 12949037
8. Small cell anaplastic carcinoma of the prostate: seven cases, review of the literature, and discussion of a therapeutic strategy. Rubenstein JH, Katin MJ, Mangano MM, Dauphin J, Salenius SA, Dosoretz DE, Blitzer PH, Am J Clin Oncol 1997 20 376 380 10.1097/00000421-199708000-00011 9256893
9. Prostate small cell carcinoma and skin metastases: a rare entity. Yildirim Y, Akcay Y, Ozyilkan O, Celasun B, Med Princ Prac 2008 17 250 252 10.1159/000117801
10. Small cell carcinoma of the prostate: a case report and review of the literature. Aygun C, Md Med J 1997 46 353 356 9260470
11. Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease. Berruti A, Mosca A, Porpiglia F, Bollito E, Tucci M, Vana F, Cracco C, Torta M, Russo L, Cappia S, Saini A, Angeli A, Papotti M, Scarpa RM, Dogliotti L, J Urol 2007 178 838 843 10.1016/j.juro.2007.05.018 17631319
12. Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate. Aoki H, Ishidoya S, Ito A, Endoh M, Shimazui T, Arai Y, Int J Urol 2006 13 1254 1258 10.1111/j.1442-2042.2006.01514.x 16984566
13. Prostate cancer with small-cell morphology: an immunophenotypic subdivision. Papandreou CN, Daliani DD, Thall PF, Tu SM, Wang X, Reyes A, Troncoso P, Logothetis CJ, Scan J Urol Nephrol 2005 39 455 463 10.1080/00365590500199855
14. Asmis T.R.,Reaume M.N.,Dahrouge S.,Malone S.,Genitourinary small cell carcinoma: A retrospective review of treatment and survival patterns at the Ottowa Hospital Regional Cancer Center BJU Int 2006 97 711-715 10.1111/j.1464-410X.2006.06041.x 16536759